Comparative evaluation of the effects of synthetic disease-modifying antirheumatic drugs and biological agents on clinical course, the rate of development of destructive changes, and quality of life in patients with rheumatoid arthritis

Comparative evaluation of the effects of synthetic disease-modifying antirheumatic drugs and biological agents on clinical course, the rate of development of destructive changes, and quality of life in patients with rheumatoid arthritis

There are few studies of the efficiency of therapy with disease-modifying antirheumatic drugs (DMARDs) and biological agents (BAs) in patients with early rheumatoid arthritis (eRA) as part of a treat-to-target strategy.Objective: to investigate the effects of DMARDs and BAs used in combination with...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Mazurov, I. B. Belyaeva, E. A. Trofimov, R. R. Samigullina, I. V. Oktyabrskaya, M. S. Petrova, O. V. Inamova, R. A. Bashkinov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-09-01
Series:Современная ревматология
Subjects:
rheumatoid arthritis
infliximab
rituximab
tocilizumab
t2tstrategy
Online Access:https://mrj.ima-press.net/mrj/article/view/930
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items